Healthtech Startups

Forema is a Japanese company working on gut microbiome analysis and lactic acid bacteria strains, including a beta microbiome analysis service for children with autism and proprietary bacterial strains. It also operates retail and other product initiatives related to these offerings.

1 investor

GENOVA operates a medical platform business (including the health media "Medical DOC") and a smart clinic business in Japan, connecting patients with healthcare providers to address concerns about medical care. Its offerings include patient management systems and AI tools for clinics and dental practices.

1 investor

HikariQ Health develops innovative immunoassay methods and antibody therapeutics using proprietary Q-body technology, a fluorescence quenching-based antibody modification technique. The company targets pharmaceutical and medical applications to improve healthcare diagnostics and therapeutics globally.

1 investor

HOKUTO is a clinical support app for physicians that provides evidence-based medical information, medical calculation tools, and knowledge management features to streamline clinical decision-making. The app targets physicians in Japan with access to drug information, clinical manuals, over 500 medical calculation tools, and document storage capabilities.

1 investor

I.W.G develops AI technology for healthcare data platforms that enable diagnostic support and data sharing in medical settings. The company works with international healthcare institutions on medical digital transformation solutions.

1 investor

IMPUTE develops digital therapy solutions for children with autism spectrum disorder, ADHD, and learning disabilities. The platform assesses individual needs and provides digital therapeutic treatments to support cognitive development.

1 investor

KORTUC develops a cancer radiotherapy (code name KRC-01) that uses hydrogen peroxide as a radiosensitizer to treat solid tumors. The company operates in the biopharmaceutical and radiation oncology space.

1 investor

NEWSTA operates the "Famicare" brand, providing information sites, a Q&A community app, a support-service search platform, and brand solutions for families raising children with illnesses or disabilities in Japan. The company connects these families with peers, experts, and businesses, focusing on diversity and inclusion around pregnancy, childbirth, and childcare.

1 investor

Onodera develops AAV vector platforms for gene therapy research targeting neurological conditions. The company owns proprietary AAV vector patents, enabling internal development of therapeutic vectors without licensing costs from third parties.

1 investor

SOXAI develops, manufactures, and sells wearable and IoT electronic devices and sensing technology for healthcare, along with related mobile/web applications and health-data analytics. The Japanese company applies non-invasive sensing technology to everyday products to support health monitoring and quality of life.

1 investor

TearExo develops a cancer detection method that analyzes exosomes in tears, aiming for a painless, non-invasive test to assess breast cancer risk and support early detection. Spun out of Kobe University in Japan, the company targets clinical screening as an alternative to blood-based and mammography testing.

1 investor

Veqta is a company that conducts genetic and health testing for pets, including dog age determination, breed identification, and disease screening. The company also offers contract research and development services for pet food evaluation, animal health monitoring devices, and veterinary solutions.

1 investor

Welby provides a Personal Health Record (PHR) platform that enables patients to record, store, and share their medical information with healthcare providers, supporting self-management of chronic diseases and other health conditions. The company serves patients and the broader healthcare ecosystem, including pharmaceutical companies, medical device manufacturers, and local governments, in Japan.

1 investor

xCARE operates a talent platform and project management service specialized for the medical industry, connecting external professional experts with pharmaceutical, medical device, and other medical product development projects. The Japan-based company aims to help startups and academic projects bring medical products to market by supplying needed specialists on a flexible basis.

1 investor

iGene develops plasma-based molecular introduction technology for cellular engineering, enabling safe and efficient delivery of DNA and proteins into cells. The company targets applications in gene therapy, regenerative medicine, agriculture, and health/beauty sectors.

1 investor

Oligogen is a Japanese biotech venture focused on regenerative medicine and drug discovery, conducting novel research and development in the pharmaceutical field.

1 investor

Qiznalo develops a wearable-free skeleton sensor system and AI that analyzes daily living activities from home environments to prevent frailty and support independent aging in place. The company provides a healthcare ecosystem that converts living spaces into health monitoring platforms using privacy-preserving motion capture technology.

1 investor

CareNet is a medical platform provider serving physicians and healthcare professionals in Japan with clinical information, medical education content, and pharmaceutical marketing support tools. The company operates a membership-based ecosystem including medical news sites, video platforms, and data analytics services for the healthcare industry.

1 investor

MiraiSpeaker develops audio hardware products and assistive hearing technology for aging populations, enabling seniors to experience enriched lives through technology.

1 investor

Shaperon builds AI software to help companies in regulated industries handle complex, industry-specific compliance and legal requirements. Its compliance AI aims to speed up work and raise compliance standards for sectors where high-stakes, expert-driven judgment is required.

1 investor

Jolly Good Inc. develops VR-based technology and content for healthcare and education, including medical training VR, social skills training VR for developmental disorders and schizophrenia, elderly-care training VR, and digital therapeutics (DTx) for psychiatric conditions. Based in Japan, the company also develops healthcare VR internationally with universities in North America and Thailand.

1 investor

Biophilia manufactures fresh pet food for dogs and cats, positioning itself as a pet wellness company that delivers nutrition and health through daily meals. The company serves pet owners in Japan and operates a Hong Kong office.

1 investor

Plusmedi Corp. develops patient-facing smartphone apps ("wellcne" and "MyHospital") and operates a personal health record (PHR) business. The company serves patients and healthcare providers in Japan.

1 investor

My Sherpa is an online counseling service operated by psychiatric specialists and doctors of medicine, offering mental health solutions including online counseling, stress checks, spot occupational physicians, and mental health training. It targets companies with corporate mental health support services in Japan.

1 investor